Article Contents ::
- 1 The Brand Name IRBEST Has Generic Salt :: Irinotecan
- 2 IRBEST Is From Company Biochem Priced :: Rs. 1368
- 3 IRBEST have Irinotecan is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name IRBEST Has Generic Salt :: Irinotecan
IRBEST Is From Company Biochem Priced :: Rs. 1368
IRBEST have Irinotecan is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| Irinotecan | INJ | Rs. 1368 | 2ML |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 2ML |
| IRBEST | Biochem | 20,45;MG | 2ML | Rs. 1368 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Biochem :: IRBEST | Irinotecan | #N/A | #N/A |
Indications for Drugs ::
Carcinoma of the colon or rectum
Drug Dose ::
Administer as a 90-minute intravenous infusion followed by LV and 5-FU. A reduction in the starting dose by one dose level may be considered for patients with any of the following conditions: prior pelvic/abdominal radiotherapy, performance status of 2, or increased bilirubin levels. Adult: IV Refractory colorectal malignancies 125 mg/m2 once wkly for 4 wk, followed by a 2 wk rest period. Metastatic colorectal cancer As 1st line treatment: 125 mg/m2 on days 1, 8, 15 and 22 of a 6-wk cycle.
Contraindication ::
Patients with a known hypersensitivity to the drug or its excipients.
Drug Precautions ::
Early diarrhea is usually transient and infrequently severe. It may be accompanied by cholinergic symptoms of rhinitis, increased salivation, miosis, lacrimation, diaphoresis, flushing, and intestinal hyperperistalsis that can cause abdominal cramping. Bradycardia may also occur. Late diarrhea can be life threatening since it may be prolonged and may lead to dehydration, electrolyte imbalance, or sepsis.Late diarrhea can be complicated by colitis, ulceration, bleeding, ileus, obstruction, and infection. Cases of megacolon and intestinal perforation have been reported.
Drug Side Effects ::
Neutropenia, anaemia, thrombocytopenia; acute diarrhoea, sweating, hypersalivation, abdominal cramps, lachrymation, miosis, weakness; nausea, vomiting, alopecia and skin reactions; cardiovascular toxicity. Potentially Fatal: Fatal sepsis due to myelosuppression; severe, chronic diarrhoea.
Pregnancy category ::
4
Drug Mode of Action ::
Irinotecan, a derivative of camptothecin, works by inhibiting the enzyme topoisomerase I thereby interfering with the coiling and uncoiling of DNA during replication and causing irreparable damage.
Drug Interactions ::
Diuretics increase risks of dehydration secondary to vomiting/diarrhoea; prophylactic dexamethasone as an antiemetic may enhance lymphocytopenia; prochlorperazine may increase incidence of akathisia; antineoplastic agents (myelosuppression and diarrhoea). St John’s wort, ketoconazole may reduce irinotecan exposure.
